Diagnosis of Toxoplasma gondii infection in pregnant women using automated chemiluminescence and quantitative real time PCR

Objective: To identify serodiagnosis and quantification of Toxoplasma gondii (T. gondii) infection among pregnant women in Salmas, northwest of Iran. Methods: In this cross-sectional study, 276 blood samples were collected from pregnant women referred to the health care centers in Salmas city. The demographic variables were also recorded. Titers of anti-Toxoplasma IgM and IgG antibodies (Ab) were determined using the chemiluminescence immunoassay. Quantitative real-time PCR targeting the T. gondii repeated element gene was also performed on the blood sample. Results: Out of all, 19.92% (55/276) and 2.17% (6/276) patients were seropositive for anti-Toxoplasma IgG and IgM Ab, respectively. Moreover, the presence of T. gondii DNA was observed in 12.31% (34/276) blood samples. A significant relationship was observed between the IgG Ab seropositivity and contact with the cat as a risk factor (P=0.022). Conclusions: The seroprevalence rate of T. gondii infection in pregnant women is relatively low. Consequently, the seronegative pregnant women are at risk, and a considerable rate of positive blood samples for the presence of parasite's DNA should not be ignored. Besides, quantitative real-time PCR could be considered as an accurate method for diagnosis of acute toxoplasmosis especially when the precise results are of the most importance in pregnancy. Limiting contact with cats is also suggested for pregnant women.

[1]  Z. Eslamirad,et al.  Toxoplasmosis: Seroprevalence in pregnant women, and serological and molecular screening in neonatal umbilical cord blood. , 2017, Acta tropica.

[2]  A. Safaiyan,et al.  Toxoplasma gondii Infection and Related Risk Factors among Blood Donors in Northwest Iran , 2017 .

[3]  A. Daryani,et al.  Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis , 2017, Tropical Medicine and Health.

[4]  A. Daryani,et al.  Evaluation of Propranolol Effect on Experimental Acute and Chronic Toxoplasmosis Using Quantitative PCR , 2016, Antimicrobial Agents and Chemotherapy.

[5]  J. Montoya,et al.  Laboratory Diagnosis of Congenital Toxoplasmosis , 2016, Journal of Clinical Microbiology.

[6]  D. Correa,et al.  Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[7]  H. Fricker-Hidalgo,et al.  Serological diagnosis of Toxoplasma gondii infection: Recommendations from the French National Reference Center for Toxoplasmosis. , 2016, Diagnostic microbiology and infectious disease.

[8]  A. Daryani,et al.  Cattle toxoplasmosis in Iran: a systematic review and meta-analysis. , 2015, Asian Pacific journal of tropical medicine.

[9]  C. Demir,et al.  Prevalence and associated risk factors of Toxoplasma gondii in female farmworkers of southeastern Turkey. , 2015, Journal of infection in developing countries.

[10]  M. Sadaghian,et al.  Prevalence of toxoplasmosis and related risk factors among humans referred to main laboratories of Urmia city, North West of Iran, 2013 , 2016, Journal of Parasitic Diseases.

[11]  A. Daryani,et al.  Excretory-secretory antigens: a suitable candidate for immunization against ocular toxoplasmosis in a murine model. , 2014, Comparative immunology, microbiology and infectious diseases.

[12]  A. Daryani,et al.  Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. , 2014, Acta tropica.

[13]  A. Daryani,et al.  Tissue tropism and parasite burden of Toxoplasma gondii RH strain in experimentally infected mice. , 2014, Asian Pacific journal of tropical medicine.

[14]  S. Rasouli,et al.  Prevalence of human toxoplasmosis and related risk factors using Electrochemiluminescence (ECLIA) method in West Azarbaijan Province, Iran, 2010 , 2014 .

[15]  P. Mastroiacovo,et al.  The global burden of congenital toxoplasmosis: a systematic review. , 2013, Bulletin of the World Health Organization.

[16]  C. Paquet,et al.  Toxoplasmosis in pregnancy: prevention, screening, and treatment. , 2013, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[17]  M. Golkar,et al.  A review on human toxoplasmosis , 2012, Scandinavian journal of infectious diseases.

[18]  M. Sadaghian,et al.  Seroprevalence of Toxoplasma gondii infection and related risk factors in Tabriz City, Iran, 2008. , 2012, Journal of research in health sciences.

[19]  M. Falagas,et al.  Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. , 2009, International journal for parasitology.

[20]  C. Gorrini,et al.  Comparison between two real-time PCR assays and a nested-PCR for the detection of Toxoplasma gondii. , 2006, Acta bio-medica : Atenei Parmensis.

[21]  A. Berrebi,et al.  Comparison between Two Amplification Sets for Molecular Diagnosis of Toxoplasmosis by Real-Time PCR , 2006, Journal of Clinical Microbiology.

[22]  D. Hill,et al.  Biology and epidemiology of Toxoplasma gondii in man and animals , 2005, Animal Health Research Reviews.

[23]  M. Skrzypczak,et al.  Recent trends in molecular diagnostics for Toxoplasma gondii infections. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[24]  P. Bastien Molecular diagnosis of toxoplasmosis. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  J. Carey,et al.  TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections. , 2002, Current women's health reports.

[26]  J. M. Rubio,et al.  Genotypic Characterization of Toxoplasma gondii Strains Associated with Human Toxoplasmosis in Spain: Direct Analysis from Clinical Samples , 2001, Journal of Clinical Microbiology.